Skip to content
NASDAQ · SERVICES-BUSINESS SERVICES, NEC · LARGE CAP

Akso Health Group AHG

11 fiscal years on record · USD · FY2025 reported · SEC filings only
$13.8M
▼ 6.4% YoY
$-18.7M
$-12.8M
▼ 1350.9% YoY

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

In brief

What this company does

On November 3, 2017, our ADSs commenced trading on the NASDAQ Global Market under the symbol “HX.” On January 26, 2022, we incorporated Qingdao Akso in Shandong Province, China and started the sales of medical devices through Qingdao Akso since April 2022. Our principal executive offices are located at Room 8201-4-4(A), 2nd Floor, Qiantongyuan Building, No. 44, Moscow Road, QianwanBonded Port Area, Qingdao Pilot Free Trade Zone, China (Shandong).

Written from the business description in Akso Health Group's annual report to the U.S. Securities and Exchange Commission, filed 23 July 2026. Every sentence was checked against that document before publication.

Growth

USD 13.8M
Revenue, FY2025 · full 11-year series below
Revenue $M Net income $M
FY2025 · Revenue 13.8 · Net income -18.7
50M100M-50M-100M
20152018202120242025
Compound annual growth
+1.6%
+50.8%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +50.8% a year over the five years to FY2025.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−135 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -149.7% · Net -135.3%
50%100%-500%-1000%
201520202025
ROE
FY2025 · ROE -9.8%
50%-50%-100%
201520202025
Three returns, three denominators.

Each USD of equity lost 10 cents this year.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -12.8
40.0M80.0M-25.0M-50.0M
201520202025
Net buybacks $M Dividends $M
FY2019 · Dividends · · Net buybacks 2.4
10M20M
20182019

Total assetsUSD 189.6M
EquityUSD 180.9M
CashUSD 170,572.00
Current ratio21.77×

Equity funds 95% of total assets.

The 11-year record

11 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
AHG, 11-year financial record
Metric 20252024202320222021202020192018201720162015
Revenue $B0.00.00.00.00.00.00.00.00.10.0◌
Operating income $B−0.0−0.2−0.0−0.0−0.0−0.0−0.0−0.00.10.00.0
EBITDA $B−0.0−0.2◌◌−0.0−0.0−0.0−0.00.10.00.0
Income tax $B−0.0−0.00.00.00.00.00.00.00.00.00.0
Net income $B−0.0−0.1−0.0−0.0−0.0−0.0−0.10.00.10.00.0
Free cash flow $B−0.00.0◌◌−0.0◌−0.1−0.00.10.00.0
EPS, diluted $−0.01−0.16−0.07−0.02−0.28−0.71−1.460.101.370.200.08
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌
Payout %———————353———
ROE %−9.8−80.0−12.9−12.9−114.0−106.5−81.64.280.145.725.3
Shares out B◌1.660.440.070.070.050.050.050.050.04◌

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 46 reconciliationsAUDITED

Reconciled in 11 of the 11 fiscal years we could check. 18 checks were skipped: the balance sheet is not tagged before 2016. Nine checks were skipped: revenue is not tagged before 2016. Eight checks were skipped: EPS is not tagged before 2015.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityServices-Business Services, NEC
Listed onNASDAQ
Incorporated inoutside the United States — SEC code E9
Fiscal year endsMarch 31
Data on record since2015

Share this section

Download image